Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, gastrointestinal (GI) and hematology, while pushing the Japanese company’s cell ...

New Jersey's powerful pharmaceutical industry, already under pressure to rein in prices, is facing new headwinds from a Trump ...

President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...

The challenge of the obesity epidemic is widespread and one that even pediatricians face constantly,” a Connecticut doctor ...

Martin Makary, President Donald Trump's nominee to run the U.S. FDA, told lawmakers on Thursday he would convene a committee ...

Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

Arthur Caplan, PhD, is the Drs. William F. and Virginia Connolly Mitty Professor and founding head of the Division of Medical Ethics at NYU Grossman School of Medicine. Lisa Kearns, MS, MA, is a ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Supply chain shortages have dominated headlines for several months, and the pharma ... FDA inspections starting again, it’s imperative that businesses reassess their processes and workforce now ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life ...

On the other hand, recent history suggests that pharma-related topics like drug pricing ... “Things did not work out well for a lot of kids I grew up with,” he said. “Every now and then ...